Article Text

PDF
Long-term outcomes of the Boston type I keratoprosthesis in eyes with previous herpes simplex virus keratitis
  1. Melinda Fry1,
  2. Carolina Aravena1,2,
  3. Fei Yu1,
  4. Jaffer Kattan1,
  5. Anthony J Aldave1
  1. 1 Stein Eye Institute, David Geffen School of Medicine at UCLA, Los Angeles, California, USA
  2. 2 Departamento de Oftalmología, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile
  1. Correspondence to Dr. Anthony J Aldave; aldave{at}jsei.ucla.edu

Abstract

Purpose To report the long-term outcomes of the Boston type I keratoprosthesis (Kpro) in eyes with prior herpes simplex virus (HSV) keratitis.

Methods Retrospective review of all Kpro procedures performed by a single surgeon from 1 May 2004 to 1 January 2015.

Results 13 of 173 Kpro procedures were performed in 11 eyes with prior HSV keratitis. There was not a significant difference in the percentage of eyes with and without prior HSV keratitis with preoperative (9% vs 8%, p=1.00) or postoperative (57% vs 60%, p=1.00) corrected distance visual acuity (CDVA) ≥20/200 or in the percentage of contralateral eyes with preoperative CDVA ≥20/50 (55% vs 30%, p=0.18). While several postoperative complications occurred approximately twice as often in eyes with prior HSV keratitis, including persistent epithelial defect (63.6% vs 34.1%; p=0.10), corneal infiltrate (27.3% vs 12.3%; p=0.17) and sterile vitritis (18.2% vs 9.4%; p=0.31), only cystoid macular oedema (45.5% vs 12.3%; p=0.01) was significantly more common. Similarly, while the Kpro retention failure rate in eyes with prior HSV keratitis was twice than that in eyes without it (0.15 vs 0.07 per year), the difference was not statistically significant (p=0.09).

Conclusion As greater than half of patients with unilateral HSV keratitis undergoing Kpro implantation have CDVA ≥20/50 in the contralateral eye, and as the Kpro retention failure rate in eyes with prior HSV keratitis is twice than that in eyes without prior HSV keratitis, caution should be exercised when considering Kpro implantation in these patients.

  • cornea
  • infection

Statistics from Altmetric.com

Footnotes

  • Contributors MF, CA and AJA: research design. MF, CA, JK and AJA: data acquisition and/or research execution. MF, CA, FY, JK and AJA: data analysis and/or interpretation. MF, CA, JK and AJA: manuscript preparation.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Ethics approval Institutional Review Board at the University of California, Los Angeles, California.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.